PharmiWeb15m
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
Zawya13m
Medcare to launch 10 world-class medical centres in two years
Medcare Medical Centres specialize in providing comprehensive healthcare services under one-roof, having integrated ...